Glue injection for chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests whether injecting a medical glue into a specific artery in the brain can safely treat a chronic subdural hematoma (a collection of blood on the brain's surface) or a recurrent subdural hematoma. This approach may offer a less invasive alternative to traditional surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a chronic subdural hematoma or a subdural hematoma that has come back after treatment.
- You agree to attend follow-up visits for up to 6 months (180 days).
- You do not have a large stroke, brain tumor, or other brain mass that needs treatment.
- You do not have a bleeding disorder (INR over 1.8 or platelet count under 80,000).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat chronic subdural hematomas (a type of bleeding on the brain) by using a very thin tube to seal off a small artery inside the head. This may help the blood clot shrink without needing a traditional surgery.
This trial tests a procedure that blocks blood flow to the membrane around the brain to treat a chronic subdural hematoma (a slow buildup of blood pressing on the brain). It may help avoid surgery and reduce symptoms like headaches, confusion, or weakness.
This trial looks at whether a procedure called middle meningeal artery embolization can help stop chronic subdural hematoma (slow bleeding/collection under the brain covering) from coming back after your first surgery. It studies an added endovascular treatment right after your operation to reduce recurrence.
This trial tests a minimally invasive procedure called middle meningeal artery embolization (using tiny particles to block a small artery) to treat chronic subdural hematoma, a condition where blood slowly builds up on the brain's surface. The goal is to help the body reabsorb the blood and prevent the need for repeated surgeries.
This trial tests adding a drug called bevacizumab (given directly into the blood vessels of the brain) to the standard procedure of middle meningeal artery embolization for a chronic subdural hematoma (a slow blood clot on the brain). The goal is to see if the combination helps reduce the chance of the clot returning.
This trial tests a procedure called coiling (placing tiny coils) to block the blood supply to a chronic subdural hematoma, a slow-growing blood collection around the brain. It may help reduce the need for surgery and improve recovery.
Hear when a new Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.